|
CIRH1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.988200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.321800E-02 |
| Normal-vs-Stage2 |
5.974800E-01 |
| Normal-vs-Stage3 |
2.284200E-02 |
| Normal-vs-Stage4 |
3.349500E-02 |
| Stage1-vs-Stage2 |
4.145000E-01 |
| Stage1-vs-Stage3 |
3.033000E-01 |
| Stage1-vs-Stage4 |
4.593000E-01 |
| Stage2-vs-Stage3 |
1.405630E-01 |
| Stage2-vs-Stage4 |
1.925030E-01 |
| Stage3-vs-Stage4 |
9.635800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.330300E-02 |
| Normal-vs-AfricanAmerican |
6.131000E-01 |
| Normal-vs-Asian |
2.094200E-01 |
| Caucasian-vs-AfricanAmerican |
5.103400E-01 |
| Caucasian-vs-Asian |
7.034200E-01 |
| AfricanAmerican-vs-Asian |
7.328200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.615810E-02 |
| Normal-vs-Female |
9.699800E-02 |
| Male-vs-Female |
1.254390E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.642200E-02 |
| Normal-vs-Age(41-60Yrs) |
4.533500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.586230E-01 |
| Normal-vs-Age(81-100Yrs) |
2.558000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.560000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.705800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.801000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.605800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.579000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.136800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.680200E-01 |
| Classical-VS-Follicular |
1.298620E-01 |
| Classical-VS-Other |
2.648600E-01 |
| Classical-VS-Normal |
2.965600E-01 |
| Tall-VS-Follicular |
9.218800E-01 |
| Tall-VS-Other |
5.576000E-01 |
| Tall-VS-Normal |
6.317800E-02 |
| Follicular-VS-Other |
5.918400E-01 |
| Follicular-VS-Normal |
4.283700E-02 |
| Other-VS-Normal |
9.969800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.865900E-02 |
| Normal-vs-N1 |
1.540870E-03 |
| N0-vs-N1 |
7.069800E-02 |
|
|
